Remove Digital Health Remove Drug Development Remove Pharmaceuticals Remove Telemedicine
article thumbnail

COVID-19 has accelerated adoption of non-contact patient monitoring technology, says Frost & Sullivan analysis

Healthcare IT News - Telehealth

“These technologies can also be leveraged by pharmaceutical companies to monitor the results of the drugs developed by them," said Ashish Kaul, technical insights senior research analyst at Frost & Sullivan. THE LARGER CONTEXT. She cites examples such as Binah.ai

article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years.

BioTech 107
article thumbnail

A guide to connected health device and remote patient monitoring vendors

Healthcare IT News - Telehealth

They provide health measures of patients and transmit them back to providers – or in some cases are reported back to providers – to facilitate healthcare decisions from afar. Typically, the health systems and payers work together in a value-based care arrangement that involves shared risk and reward. Bardy Diagnostics.